To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Chennai, Nov. 26 -- Highlights: ...
Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...
Gene-edited crops are no safer than GMOs, and fast-tracking regulatory approval could trigger a costly backlash.
The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...
Thinking about whether CRISPR Therapeutics stock is truly a bargain or just the next biotech craze? Let’s break down its value case together. After a sharp rally earlier this year, the stock is still ...
M OST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had ...
India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback